ֱ

We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at

Prof. Lawrence Kazak discusses his most recent publication and scientific collaboration

Prof. Lawrence Kazak's lab just published an article entitled "ADRA1A-G⍺q signalling potentiates adipocyte thermogenesis through CKB and TNAP" in the journal Nature Metabolism, on a project led by postdoctoral fellow Janane Rahbani.

What would you highlight as the most important finding of this paper?

The conventional view of adipocyte thermogenesis activation is through adrenergic receptor (encoded by ADRB3) stimulation, signaling through cyclic AMP, and thermogenesis by uncoupling protein 1 (UCP1). We find that activation of the alpha-adrenergic receptor (encoded by ADRA1A) potentiates thermogenesis by the cyclic AMP-UCP1 axis by triggering a parallel pathway of thermogenesis called the Futile Creatine Cycle.

How is this finding helping to advance the science of cancer?

Since thermogenesis requires the combustion of metabolic fuels, activating brown fat thermogenesis may compete for nutrients that cancer cells use to promote their proliferation.

What other institutions did you collaborate with on this study?

We had many collaborators for this project: the University of Birmingham, theUniversity of Pennsylvania, theUniversity of Copenhagen, theMaine Medical Center Research Institute, theJoslin Diabetes Center at Harvard Medical School, theBeth Israel Deaconess Medical Center at Harvard Medical School, the University of California, Davis, theWashington University School of Medicine,Rutgers University, the Johns Hopkins University School of Medicine, theNational Institute of Diabetes and Digestive and Kidney Diseases at the National Institute of Health, and Aarhus University.

Back to top